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INTRODUCTION
Medication errors frequently result in adverse 
drug events. These errors greatly impact patient 
safety, representing the leading cause for injuries 
and death.1  Studies have reported at least one error 
per patient encounter.2 An emergency department 
(ED) setting is believed to be particularly sensitive 
to medication errors due to exposure to new 
patients, time constraints, frequent interruptions 
and limited patient history.1,3 Additionally, there is 
a higher frequency of prescriptions in this setting, 
with more than 75% of ED visits resulting in drug 
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Abstract
Introduction: Medication errors are common, with studies reporting at least one error per patient encounter. 
At hospital discharge, medication errors vary from 15%-38%. However, studies assessing the effect of an 
internally developed electronic (E)-prescription system at discharge from an emergency department (ED) 
are comparatively minimal. Additionally, commercially available electronic solutions are cost-prohibitive 
in many  resource-limited settings. We assessed the impact of introducing an internally developed, low-
cost E-prescription system, with a list of commonly prescribed medications, on prescription error rates at 
discharge from the ED, compared to handwritten prescriptions.
Methods: We conducted a pre- and post-intervention study comparing error rates in a randomly selected 
sample of discharge prescriptions (handwritten versus electronic) five months pre and four months post 
the introduction of the E-prescription. The internally developed, E-prescription system included a list of 
166 commonly prescribed medications with the generic name, strength, dose, frequency and duration. We 
included a total of 2,883 prescriptions in this study: 1,475 in the pre-intervention phase were handwritten 
(HW) and 1,408 in the post-intervention phase were electronic. We calculated rates of 14 different errors 
and compared them between the pre- and post-intervention period.
Results: Overall, E-prescriptions included fewer prescription errors as compared to HW- prescriptions. 
Specifically, E-prescriptions reduced missing dose (11.3% to 4.3%, p <0.0001), missing frequency (3.5% 
to 2.2%, p=0.04), missing strength errors (32.4% to 10.2%, p <0.0001) and legibility (0.7% to 0.2%, 
p=0.005). E-prescriptions, however, were associated with a significant increase in duplication errors, 
specifically with home medication (1.7% to 3%, p=0.02).
Conclusion: A basic, internally developed E-prescription system, featuring commonly used medications, 
effectively reduced medication errors in a low-resource setting where the costs of sophisticated commercial 
electronic solutions are prohibitive.
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administration or prescription dispensing.4 Errors 
at discharge in particular are also common, varying 
from 15%-38%.5-8 Of discharged patients from the 
hospital, 23% encountered at least one adverse 
event and 72% of the adverse events were attributed 
to medications errors.9
To our knowledge, a total of two studies have 
looked at the impact of electronic (E)-prescription 
error rates at discharge from the ED. Bizovzi et al. 
found that a commercial E-prescription system was 
three times less likely to result in errors and five 
times less likely to demand pharmacist clarification 
than hand-written (HW) prescriptions within the 
ED.10 A similar effect was reported at discharge in a 
pediatrics ED with a commercially-based system.11
This study examined the effect of introducing a low- 
cost, internally developed E-prescription system 
with a list of commonly prescribed medications 
to the ED at a tertiary care center in Lebanon, on 
prescription errors compared to HW-prescriptions.
METHODS
Study Setting
This study was conducted at the ED of the 
American University of Beirut Medical Center, the 
largest tertiary care center in Lebanon, with around 
49,000 patient visits per year. The ED is staffed by 
attendings around the clock along with residents 
from multiple different services for adult patients 
(internal medicine, family medicine, surgery and 
obstetrics residents) and pediatric patients (family 
medicine and pediatrics residents). The majority 
of our patients are covered by private third-party 
payers (67%), while the remaining pay out of 
pocket. The ED uses an internally developed 
dashboard system that allows for patient tracking, 
electronic diagnostics ordering and review of prior 
visits and diagnostics results. All ED medication 
ordering throughout the ED stay is done through 
hand-written orders (HW), including at discharge.
Study Design
We conducted a pre- and post-intervention 
study with a random sample of patients selected 
from the pre- and post- intervention period. The 
pre-intervention phase, which included the HW-
prescription at discharge, ran from November 1, 
2010- June 30, 2011, while the post-intervention 
phase, which included the E-prescriptions, ran from 
November 1, 2011-June 30, 2012. These periods 
were selected to allow for a wash-out period, 
specifically one month pre-introduction of the 
E-prescription and two months post-introduction, 
during which piloting and implementation was 
occurring. Approval for this study was granted by 
our institutional review board.
Population Health Research Capsule
What do we already know about this 
issue? Commercially available electronic 
prescription systems decrease prescription 
errors at ED discharge however they are cost-
prohibitive in resource limited settings.
What was the research question?
Assess the impact of introducing an 
internally developed, low-cost electronic 
prescription system on prescription error 
rates at ED discharge.
What was the major finding of the study? 
An electronic prescription system featuring 
commonly used ED medications reduced 
prescription errors at ED discharge.
How does this improve population health? 
Reducing prescription errors at discharge 
from the ED, by applying a basic electronic 
prescription system, can prevent adverse drug 
events and improve quality of care.
Sample selection
Patients eligible in this study were of all ages, 
genders, and diagnoses, with at least one 
prescription at discharge, either HW or electronic. 
We excluded patients whose charts were not 
scanned into the electronic medical record or if the 
discharge prescription was missing. We randomly 
selected charts for the pre-intervention month, by 
selecting every 10th admission medical record 
number, checking for the presence of a discharge 
prescription. If so, the patient was included in the 
study. This process was repeated until the target 
number of patients was reached. We also used this 
method for the post- intervention group.
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Power calculation
Although the HW-prescribing error rate in the 
literature ranges between 15-46%,12,13 for the sample 
size calculation of the current study, we considered 
a rate of 50%, since it yields the highest sample size 
(most conservative). Accordingly, we estimated 
that a sample size of 770 patients in each group 
was needed to detect a 7% reduction in error rates 
post- intervention, with an 80% power and an alpha 
level of 5%, assuming one discharge prescription 
per patient.
Intervention
An electronic discharge process was internally 
developed by a team that included an emergency-
physician champion working with the hospital 
information technology (IT) team and director of 
pharmacy. The electronic discharge module was 
introduced on August 1, 2011. The new system 
included forced fields for diagnoses, an optional 
section for follow-up care, optional patient 
education handouts and a prescription section that 
included 166 commonly prescribed medications 
with the generic name of the medication, strength, 
dose, frequency, route, and duration. The list was 
developed based on historical data of commonly 
prescribed medications from the ED, in addition 
to faculty input. When deciding on common 
medication categories where multiple options 
exist, we included the ones on hospital formulary, 
e.g., esomeprazole rather than pantoprazole. For 
pediatrics, the list included the medication, strength 
and recommended dosing only on a mg/kg basis, 
where the final dose required manual calculation. 
Hospital pharmacy reviewed the final list for 
accuracy and availability of medications in the 
local market. The system did not include allergy- 
or medication- reconciliation functions. Physicians 
could also free text additional medications without 
forced fields. The time to complete and print the 
E-prescription was around 30 seconds. The total 
cost of development and implementation including 
IT personnel time, ED medical director time and 
pharmacist time was approximately $4,300 U.S. in 
our setting.
Data collection
The methods followed in this study adhere to the 
criteria suggested by Worster et al. for retrospective 
chart review.14 We used a data collection sheet to 
facilitate extracting the information and to de-
identify the phase of the study. Two research 
assistants who were trained prior to data collection 
and monitored throughout transcribed both the HW- 
and E-prescriptions into a Microsoft Excel database. 
We reviewed medical charts retrospectively to 
collect patient-specific demographic and medical 
data including age, gender, emergency severity 
index (ESI), discharge diagnosis, allergies, 
home and discharge medications (number and all 
prescription-related information on medication 
name, dose, strength, frequency, route, and duration) 
and number of handovers as reflected by attending 
shift changes during the patient’s stay.
Moreover, we used an administrative database 
to collect workload and scheduling metrics that 
might affect error rates. These included ED visit 
volume per day, weekday/weekend shift, shift type 
(morning shift, which ran from 8am-4pm; evening 
shift, 4pm to midnight; and night shift, midnight to 
8am).
Definitions and identification of errors
The definition of errors in each prescription 
was according to the error list provided in Table 
1. Duplication with discharge medication was 
considered an error when two medications of 
the same family were included in the discharge 
prescription, for example, ibuprofen and naproxen. 
We considered duplication with home medications 
an error when at least one of the discharge 
medications was of the same family as one of the 
home medications and there were no instructions 
to hold or stop the home medication. Drugs were 
reviewed for interactions with all the medications 
listed in the discharge prescription list and the 
home medication list. We used Lexicomp® drug 
interaction software to check for all interactions 
and risk ratings as per the software, where risk A 
involved no known interaction, risk B required no 
action, risk C required monitoring therapy, risk 
D required consideration of therapy modification 
and risk X required avoidance of combination.15 
All risk D and X interactions were considered an 
error. We included drug allergy error if the patient 
was discharged on a medication that was listed 
as an allergy in the patient record, or was of the 
same family of the allergy medication. Lexicomp 
software was also used to review all medication 
dosing, frequency, and duration recommendations. 
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A prescription was considered to have an error in 
these categories if there was deviation from the 
Lexicomp recommendation. Incorrect strength was 
considered an  error  if the strength of the medication 
was not one available in the local market per the 
Lebanese Ministry of Public Health formulary 
list.16 A medication was considered illegible if the 
research assistant was unable to read it. The two 
research assistants who extracted the data completed 
the error scoring. Moreover, to verify the scoring, a 
clinical pharmacist, who was blinded to the purpose 
Table 1 Types of errors in prescriptions for discharge 
medication, and corresponding risk level.
Description Risk level classification
High-risk errors
Duplication with discharge medication High
Duplication with home medication High
Drug/drug interaction (D/H) High (type D and X)
Drug/drug interaction (D/D) High (type D and X)
Drug/allergy interaction High
Incorrect dose High
Incorrect frequency High
Incorrect strength of drug High
Low-risk errors
Incorrect route Low
Missing duration Low
Missing dose Low
Missing frequency Low
Missing strength of drug Low
  Illegibility  Illegible  
Drug/drug interaction (D/H): interaction of discharge 
medications with home medications. Drug/drug interaction 
(D/D): interac- tions of discharge medication with another 
discharge medication. Type D required consideration of therapy 
modification and type X required avoidance of combination.
and phase of the study, reviewed the de-identified 
data and scored them independently. Finally, any 
discrepancy between the scoring of the research 
assistants (RAs) and the pharmacist was resolved by 
discussion with the principal investigator (PI) of the 
study, as well as the director of clinical pharmacy at 
our institution.
Outcomes and classification of errors
Primary outcomes
We classified errors directly impacted by the 
intervention as primary outcomes. These included 
incorrect route, dose, or frequency, or strength, 
illegibility and missing duration, dose, frequency, 
or strength.
Other outcomes
Errors that were not directly targeted by the 
intervention but were felt to potentially impact 
patient safety were considered other outcomes. 
These included the following: duplication with 
discharge medication, duplication with home 
medications, interactions of discharge medication 
with another discharge medication, interaction of 
discharge medications with home medications and 
drug/allergy interaction.
Classifications
A priori, we categorized those under 14 years of 
age as pediatric, and those above as adults. This 
classification was based on a previous study, where 
the age group corresponds to a typical weight of 
50kg or less and is likely to need weight-based 
prescription dosing.10 The error types were classified 
into three groups: incorrect errors (incorrect route, 
dose, frequency, and strength), missing information 
errors (missing duration, dose, frequency, and 
strength) or illegible errors. Error types were also 
grouped  as high  or low risk. We  considered 
errors  high  risk       if they had the potential to 
cause significant harm and were not part of routine 
pharmacist verification practice. All missing- 
information errors were considered low risk as 
pharmacy verification would be required to fill the 
prescription. High-risk errors included duplication 
with discharge medication, drug/ drug interaction 
with home medications, drug/drug interaction with 
discharge medications, drug/allergy interaction, 
incorrect dose, incorrect frequency, incorrect 
strength, and duplication with home or discharge 
medication. Low-risk errors included incorrect 
route, missing duration, missing dose, missing 
frequency, and missing strength.
Statistical Analysis
We used the Statistical Package for Social Sciences 
(SPSS) ® for the data management and analyses. 
The distribution of the medication errors and the 
predictors (sociodemographic characteristics, ED 
scheduling, ED workload and patient medical status) 
are presented as means ± standard deviations (SD) 
and frequencies and percentages for the continuous 
and categorical variables, respectively. We used 
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Table 2. Association between the demographic variables and the use of handwritten (HW) or electronic (E) prescription.
Pre-intervention HW
number (%)
Post-intervention E
number (%)
Total sample N=1475 N=1408 p value
Patient characteristics
Age (years) (Mean, ±SD) 31.4 (±20.9) 31.3 (±20.0) 0.81
Male gender 746 (50.6%) 715 (50.8%) 0.91
ESI (Mean, ±SD) 3.3 (±0.6) 3.3 (±0.7) 0.10
Pediatric patients Pediatric 320 (21.7%) 268 (19.0%) 0.08
Number of home medications/patient (Mean, ±SD) 1.3 (±1.7) 1.1 (±1.6) 0.002
Number of discharge medications/patient (Mean, ±SD) 2.4 (±1.0) 2.3 (±1.0) 0.001
ED workload
Shift 0.001
Morning 528 (35.8%) 485 (34.4%)
Evening 575 (39.0%) 485 (34.4%)
Night 372 (25.2%) 438 (31.1%)
Handovers per visit (Mean, ±SD) 1.1 (±0.3) 1.2 (±0.4) 0.33
ED volume per day (Mean, ±SD) 134.1 (±13.4) 132.4 (±16.4) 0.002
HW, handwritten prescriptions; E, electronic prescriptions; ESI, Emergency Severity Index; SD, standard deviation.
Table 3. Association between the type of errors and the use of handwritten (HW) or electronic (E) prescriptions.
Pre-intervention HW
number (%)
Post-intervention E
number (%)
Total sample N=1475 N=1408 Crude OR (95% CI) p value
All type errors 999 (67.7%) 641 (45.5%) 0.40 (0.34 – 0.46) <0.0001
Duplication with discharge 5 (0.3%) 4 (0.3%) 0.84 (0.22 – 3.13) 1.00
Drug/drug interaction (D/H) 107 (7.3%) 96 (6.8%) 0.94 (0.70 – 1.25) 0.65
Drug/drug interaction (D/D) 51 (3.5%) 55 (3.9%) 1.14 (0.77 – 1.67) 0.52
Drug/allergy interaction 0 (0.0%) 2 (0.1%) - 0.24
Incorrect drug 2 (0.1%) 1 (0.1%) 0.52 (0.05 – 5.78) 1.00
Incorrect dose 40 (2.7%) 26 (1.8%) 0.68 (0.41 – 1.11) 0.12
Incorrect frequency 51 (3.5%) 57 (4.0%) 1.18 (0.80 – 1.73) 0.40
Illegibility 11 (0.7%) 1 (0.1%) 0.10 (0.01 – 0.73) 0.005
Missing duration 398 (27.0%) 410 (29.1%) 1.11 (0.95 – 1.31) 0.20
Missing dose 166 (11.3%) 61 (4.3%) 0.36 (0.26 – 0.48) <0.0001
Missing frequency 51 (3.5%) 31 (2.2%) 0.63 (0.40 – 0.99) 0.04
Missing strength 478 (32.4%) 144 (10.2%) 0.24 (0.19 – 0.29) <0.0001
Incorrect strength 22 (1.5%) 51 (3.6%) 2.48 (1.50 – 4.12) <0.0001
Duplication with home medication 25 (1.7%) 42 (3.0%) 1.78 (1.08 – 2.94) 0.02
HW, handwritten prescriptions; E, electronic prescriptions Drug/drug interaction (D/H): interaction of discharge 
medications with home medications. Drug/drug interaction (D/D): interactions of discharge medication with another 
discharge medication.
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Pearson’s chi-squared and one- way Student’s t-test 
to assess the significance of the association between the 
predictor factors (continuous and categorical) and the 
medication error.
We performed a multivariate analysis using 
logistic egression to find the best model that fit 
the data and explained the association between 
medication error and all predictor
variables, which included the following: type of 
prescription, age, gender, ESI, number of home 
medications, number of discharge medications, 
shift type, ED volume per day and handovers per 
visit. We conducted a backward selection procedure 
by fitting medication error with all risk factors 
found to be significant at the bivariate level, in 
addition to those considered clinically meaningful. 
Furthermore, the magnitude of association between 
the predictor variables and medication errors was 
determined by calculating the adjusted odds ratios 
(aOR) and their corresponding 95% confidence 
intervals (CI). Missing data were not modified, 
and statistical significance was established at the 
p-value of 0.05.
RESULTS
We included a total of 2,883 prescriptions in the 
study, of which 1,475 (51.2%) were in the pre-
intervention period (HW), and 1,408 (48.8%) in the 
post-intervention (E). Table 2 presents the results of 
the comparison of the demographic characteristics 
and the ED workload data between the pre- and 
post-intervention periods. Overall, characteristics 
of both patient populations were similar, although 
there was a slight decrease in the number of home 
medications and discharge medications per patient 
in the post- intervention period (1.3 prescription 
per patient compared to 1.1, p=0.002). As for the 
workload characteristics, the ED workload per day, 
though not clinically significant, was lower in the 
post- intervention period (132.4 vs 134.1, p=0.002) 
with more patients presenting during the night shift 
(31.1% vs 25.2%, p=0.001).
Overall, E-prescriptions were significantly 
associated with a reduced error rate (67.7% vs 
45.5%, p<0.0001) (OR=0.40, 95%, CI [0.34–0.46]) 
(Table 3). More specifically, E-prescriptions were 
associated with a significant reduction of “missing 
dose” errors (11.3% vs. 4.3%, OR=0.36, 95% CI 
[0.26–0.48], p <0.0001), “missing frequency” 
errors (3.5% vs. 2.2%, OR=0.63, 95% CI [0.40–
0.99], p=0.04), and “missing strength” errors 
(32.4% vs 10.2%, OR=0.24, 95% CI  [0.1–0.29], p 
<0.0001). “Legibility” also significantly improved 
with E-prescriptions (0.7% vs 0.1%, OR=0.10, 
Table 4. Association between the types of prescribing errors by broad categories and the use of electronic or handwritten 
prescription.
Pre-intervention HW
number (%)
Post-intervention E
number (%)
Total sample N=1475 N=1408 p value
Drug interaction errors 128 (8.7%) 140 (9.9%) 0.24
Incorrect information errors 103 (7.0%) 126 (8.9%) 0.05
Illegible errors 11 (0.7%) 1 (0.1%) 0.005
Missing information errors 870 (59.0%) 500 (35.5%) <0.0001
Drug allergy errors 0 (0.0%) 2 (0.1%) 0.24
HW, handwritten prescriptions, E, electronic prescriptions
Table 5. Comparison between handwritten and electronic prescriptions according to the risk level.
Pre-intervention HW
number (%)
Post-intervention E
number (%)
Total sample N=1475 N=1408 p value
All errors 985 (66.8%) 626 (44.5%) <0.0001
Low-risk errors 871 (59.1%) 500 (35.5%) <0.0001
High-risk errors 221 (15.0%) 256 (18.2%) 0.02
Illegible errors 11 (0.7%) 1 (0.1%) 0.005
HW, handwritten prescriptions, E, electronic prescriptions
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95% CI [0.01–0.73], p=0.005). On the other hand, 
E-prescriptions were associated with a significant 
increase of “incorrect strength” errors (1.5% vs. 
3.6%, OR=2.48, 95% CI [1.50– 4.12], p <0.0001) 
and “duplication with home medication” (1.7% vs. 
3.0%, OR=1.78, 95% CI [1.08–2.94], p =  0.02).
When classified into broad categories of 
prescription error types, “missing information” 
(which includes missing duration, route, dose, 
strength, name, and frequency)  was the most 
common type of error to occur overall  (47.5%) and 
was significantly less common in E-prescriptions 
as compared to the HW-prescriptions (35.5% vs 
59.0%, respectively, p <0.0001) (Table 4). On the 
other hand, “incorrect information” (which includes 
incorrect route, dose, and frequency) errors were 
more common in prescriptions, with borderline 
statistical significance (8.9% vs 7.0%, p=0.05).
Table 5 presents the comparison between the 
HW- and E-prescriptions by risk level of errors. 
Low-risk prescribing errors were the most common 
type of errors in  both groups, yet it was found to 
be less in the E-prescriptions as compared to the 
HW (35.5% vs. 59.1%, p  <0.0001). Similarly, the 
illegible errors were less in the E-prescription (0.1% 
vs 0.7%, p= 0.005). On the other hand,  high-risk 
errors were more common in the E-prescriptions as 
compared to the HW ones (18.2% vs 15.0%, p = 
0.02).
The results of the multivariate logistic regression 
analysis for the predictors of all types of medication 
errors are presented in Table 6. After adjusting for 
potentially confounding factors, it was found that 
E-prescriptions were a strong predictor of fewer 
errors (adjusted OR = 0.40, 95% CI [0.35 – 0.47], 
p<0.0001).
DISCUSSION
This pre- / post-intervention study demonstrates 
that the implementation of a low-cost, internally 
developed E-prescription system, featuring a list 
of commonly used medications, with no decisional 
support features, can effectively reduce the number 
of medication errors. While multiple studies 
have demonstrated the impact of sophisticated 
E-prescription system on reducing prescribing 
errors at discharge, the expense of such systems 
may be prohibitive in low-resource settings.
The types of errors significantly reduced with 
E-prescriptions in our study were the following: 
missing dose, missing frequency, missing strength, 
and illegibility errors. In terms of broad categories of 
errors, low-risk errors, illegible errors and missing-
information errors emerged as significantly reduced 
by E-prescription. By contrast, incorrect information 
errors were more common in E-prescriptions. This 
was mainly due to an incorrect strength of one 
commonly used medication that was included in the 
final list and perpetuated in all the E-prescriptions.
Our study revealed no improvement in the 
other outcomes. In fact, duplication with home 
medications increased upon E-prescription use while 
no such  effect was noted for drug-interaction errors 
and drug-allergy errors. This was likely because 
the design of the  internally developed system in 
our study did not  specifically target high-risk 
errors or include drug-allergy checking, medication 
reconciliation, and drug-drug interaction features. 
Since no controls for these errors were introduced, 
the difference in corresponding error rates between 
pre-  and post-intervention was expectedly not large. 
Overall, this is in line with previous studies in which 
computerized systems were not as effective with 
high-risk medication errors.17,18 Such high-risk 
errors would require developing more sophisticated 
programs that include fields for entering home 
medications and allergies, which could then be 
cross- checked with the discharge medications for 
Table 6. Multivariate analysis for the predictors of all types of medication errors vs no errors (hierarchical method imposing 
the type of prescription).
Predictors Adjusted OR (95%CI) P value
Type of prescription (handwritten/electronic) 0.40 (0.35 – 0.47) <0.0001
Age 1.01 (1.01 – 1.02) <0.0001
Pediatrics 1.38 (1.06 – 1.78) 0.02
Number of home medications per patient 1.18 (1.11 – 1.25) <0.0001
Variables entered in the model include the following: type of prescription, total visits, ED volume, age, gender, (Emergency 
Severity In- dex), pediatric (as compared to adult) patients, number of home medications per patient, number of discharge 
medications per patient, shift evening, shift night.
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interactions/ contraindications.
In addition, although the current system includes 
a list of commonly prescribed medications, a 
free-text option remained available to providers. 
This may have  reduced the impact on missing-
information errors. Implementing a program that 
makes some elements mandatory would be an easy, 
low-cost modification that would further mitigate 
this type of error.
Features of commercially available E-prescription 
systems range from basic medication lists to 
robust decision-making support with medication 
reconciliation processes. While decision support 
capability to address  high-risk errors is an 
important component of  commercially available 
E-prescription systems, such complex systems can 
cost up to $29,000 per physician for the first year 
and $4,000 annually thereafter.19 Even the cost of 
commercially available E-prescriptions systems 
with basic features is high, ranging between $1,500 
and $4,000 per physician.
Such costs are likely unaffordable in low-resource 
settings where internally developed solutions may 
offer more feasible options.
LIMITATIONS
There are a few limitations to this study. Firstly, 
this intervention was implemented across a single 
institution, which may limit generalizability. Given 
the pre-/post study design, some physician- and 
patient-related characteristics may have varied and 
introduced a bias into the results. Additionally, 
the outcome and  consequences of medication 
errors and their severity, including adverse drug 
events, were not measured and assessed. Moreover, 
although discrepancy between abstractors was 
resolved through a systematic process with the 
PI, nevertheless, inter-observer reliability was not 
tested.
CONCLUSION
An E-prescription system that includes a common 
list of ED medications considerably decreased the 
frequency of the majority of prescription errors. To 
date, no studies have investigated the impact of a 
low-cost electronic, internally developed system in 
an ED where   resources are limited and acquiring 
comprehensive and commercial E-solutions is cost-
prohibitive. The developed system  is comparatively 
more basic than currently available systems and 
uses entirely internal resources. The decrease 
in error rates introduced by this cost-effective 
system supports its implementation, particularly 
in developing countries with limited financial 
resources.
Conflict of interest: No author has professional or 
financial relationships with any companies that 
are relevant to this study. There are no conflicts 
of interest or sources of funding to declare.
REFERENCES
1. Hummel J, Evans PC, Lee H. Medication reconciliation 
in the emergency department: opportunities for workflow 
redesign. Qual Saf Health Care. 2010;19(6):531-5.
2. Institute of Medicine. Preventing medication errors. 
Washington, DC: National Academies Press; 2006.
3. Sard BE, Walsh KE, Doros G, et al. Retrospective evaluation 
of a computerized physician order entry adaptation to prevent 
prescribing errors in a pediatric emergency department. 
Pediatrics. 2008;122(4):782-7.
4. Pitts SR, Niska RW, Xu J. et al., National Hospital 
Ambulatory Medical Care Survey: 2006 emergency 
department summary. Natl Health Stat Report. 2008;(7):1-38.
5. Croskerry P, Shapiro M, Campbell S, et al. Profiles in Patient 
Safety: Medication Errors in the Emergency Department. 
Acad Emerg Med. 2004;11(3):289-99.
6. Morrill GB, Barreuther C. Screening discharge prescriptions. 
Am J Hosp Pharm. 1988;45(9):1904-5.
7. Schumock GT, Guenette AJ, Keys TW, et al. Prescribing 
errors for patients about to be discharged from a university 
teaching hospital. Am J Hosp Pharm. 1994;51(18):2288-2290.
8. Wong JD, Bajcar JM, Wong GG, et al. Medication 
reconciliation at hospital discharge: evaluating discrepancies. 
Ann Pharmacother. 2008;42(10):1373-9.
9. Forster AJ, Clark HD, Menard A, et al. Adverse events 
among medical patients after discharge from hospital. CMAJ, 
2004;170(3):345-9
10. Bizovi KE, Beckley BE, McDade MC, et al. The effect 
of computer- assisted prescription writing on emergency 
department prescription errors. Acad Emerg Med. 
2002;9(11):1168-75.
11. Upperman JS, Staley P, Friend K, et al. The impact of 
hospitalwide computerized physician order entry on medical 
errors in a pediatric hospital. J Pediatr Surg. 2005;40(1):57-9.
MedJEM Hitti e et al.
Volume 1 | Issue 1 | September 2019                        Mediterranean Journal of Emergency Medicine & Acute Care 11
12. Dean B, Barber N, Schachter M. What is a prescribing 
error? Qual Health Care. 2000;9(4):232-7.
13. Radley DC, Wasserman MR, Olsho LE, et al. Reduction in 
medication errors in hospitals due to adoption of computerized 
provider order entry systems. J Am Med Inform Assoc. 
2013;20(3):470-6.
14. Worster A, Bledsoe RD, Cleve P, et al. Reassessing the 
methods of medical record review studies in emergency 
medicine research. Ann Emerg Med. 2005;45(4):448-51.
15. Login.Online.lexi.com. 2016. Available at: http://online.
lexi.com/action/home. Accessed on August 10, 2016
16. MOPH. moph.gov.lb. 2016. Available at: http://www.
moph.gov.lb/en/ Drugs/index/3/4848/lebanon-national-drug-
index-lndi. Accessed on August 9, 2016.
17. Bates DW, Leape LL, Cullen DJ, et al. Effect of 
computerized physician order entry and a team intervention 
on prevention of serious medication errors. JAMA. 
1998;280(15):1311-6.
18. Gandhi TK, Weingart SN, Seger AC, et al. Outpatient 
prescribing errors and the impact of computerized prescribing. 
J Gen Intern Med. 2005;20(9):837-41.
19. Hahn A, Lovett A. Electronic prescribing: an examination 
of cost effectiveness, clinician adoption and limitations. 
UJCM. 2014;2(1):1-24.
MedJEM Hitti e et al.
Volume 1 | Issue 1 | September 2019                        Mediterranean Journal of Emergency Medicine & Acute Care 12
